Literature DB >> 11641551

Definition of fetal growth restriction according to constitutional growth potential.

N Mamelle1, V Cochet, O Claris.   

Abstract

Identification of newborn babies with fetal growth restriction remains a problem both from the multi-factorial aspect of fetal growth and from statistical definition. Besides the usual terms: "Small for gestational age" (SGA) and intrauterine growth retardation (IUGR), often used synonymously, the term "fetal growth retardation" was recently introduced in reference to the genetic growth potential of infants. From a sample of 72,000 births, we have designed a statistical model in order to estimate the expected birth weight taking into account gestational age, sex, birth rank, maternal age, height and pregravid weight, we then calculated an individual limit of birth weight under that a newborn must be considered as having a "fetal growth restriction" quoted FwGR. This new approach allowed us to identify 2 groups of newborns with FGR, one classically identified as SGA (noted FwGR(I)) (3.9%), and the other newly identified as FGR (noted FwGR(II)) (1.4%). In contrast, this approach allowed us to identify a group of "constitutionally small" infants according to their constitutional growth potential (1.1%). In other words, among infants usually defined as SGA (5%), 22% appeared in fact to be "constitutionally small" and therefore misclassified. As an initial validation, we observed that the proportion of maternal hypertension during pregnancy was low in the "constitutionally small" infants (close to that of the normal group), and three times higher in the newly identified group FwGR(II) than in the normal group. Following these results, it seems to be meaningful to follow-up this new group of FwGR(II) infants, in terms of catch-up growth and neurodevelopmental outcome. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11641551     DOI: 10.1159/000047157

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  19 in total

1.  Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.

Authors:  Walter K Kraft; Kevin Dysart; Jay S Greenspan; Eric Gibson; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Addiction       Date:  2010-10-06       Impact factor: 6.526

2.  The first 50 live births after autologous oocyte vitrification in France.

Authors:  Any Beltran Anzola; Vanessa Pauly; Cendrine Geoffroy-Siraudin; Marie-José Gervoise-Boyer; Debbie Montjean; Pierre Boyer
Journal:  J Assist Reprod Genet       Date:  2015-10-30       Impact factor: 3.412

3.  Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential.

Authors:  Nicole Mamelle; Magali Boniol; Olivier Rivière; Marie O Joly; Georges Mellier; Bernard Maria; Bernard Rousset; Olivier Claris
Journal:  Eur J Pediatr       Date:  2006-07-12       Impact factor: 3.183

4.  Deficit of vitamin D in pregnancy and growth and overweight in the offspring.

Authors:  E Morales; A Rodriguez; D Valvi; C Iñiguez; A Esplugues; J Vioque; L S Marina; A Jiménez; M Espada; C R Dehli; A Fernández-Somoano; M Vrijheid; J Sunyer
Journal:  Int J Obes (Lond)       Date:  2014-09-05       Impact factor: 5.095

Review 5.  The Auxological and Metabolic Consequences for Children Born Small for Gestational Age.

Authors:  Wayne Cutfield; Ahila Ayyavoo
Journal:  Indian J Pediatr       Date:  2021-08-17       Impact factor: 1.967

6.  Impact on fetal growth of prenatal exposure to pesticides due to agricultural activities: a prospective cohort study in Brittany, France.

Authors:  Claire Petit; Cécile Chevrier; Gaël Durand; Christine Monfort; Florence Rouget; Ronan Garlantezec; Sylvaine Cordier
Journal:  Environ Health       Date:  2010-11-15       Impact factor: 5.984

7.  Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.

Authors:  Walter K Kraft; Eric Gibson; Kevin Dysart; Vidula S Damle; Jennifer L Larusso; Jay S Greenspan; David E Moody; Karol Kaltenbach; Michelle E Ehrlich
Journal:  Pediatrics       Date:  2008-08-11       Impact factor: 7.124

8.  Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.

Authors:  Patrick Hanna; Virginie Grybek; Guiomar Perez de Nanclares; Léa C Tran; Luisa de Sanctis; Francesca Elli; Javier Errea; Bruno Francou; Peter Kamenicky; Léa Linglart; Arrate Pereda; Anya Rothenbuhler; Daniele Tessaris; Susanne Thiele; Alessia Usardi; Ashley H Shoemaker; Marie-Laure Kottler; Harald Jüppner; Giovanna Mantovani; Agnès Linglart
Journal:  J Bone Miner Res       Date:  2018-06-07       Impact factor: 6.741

9.  Urinary biomarkers of prenatal atrazine exposure and adverse birth outcomes in the PELAGIE birth cohort.

Authors:  Cécile Chevrier; Gwendolina Limon; Christine Monfort; Florence Rouget; Ronan Garlantézec; Claire Petit; Gaël Durand; Sylvaine Cordier
Journal:  Environ Health Perspect       Date:  2011-03-02       Impact factor: 9.031

10.  Prenatal Exposure to Polybrominated Flame Retardants and Fetal Growth in the INMA Cohort (Spain).

Authors:  Maria-Jose Lopez-Espinosa; Olga Costa; Esther Vizcaino; Mario Murcia; Ana Fernandez-Somoano; Carmen Iñiguez; Sabrina Llop; Joan O Grimalt; Ferran Ballester; Adonina Tardon
Journal:  Environ Sci Technol       Date:  2015-08-04       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.